SCHEMBL1665166

SCHEMBL1665166

[CH2]c1c(C)ccc[n+]1[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2512414 0.75 ACHE (0.38)
SCHEMBL538571 0.75
SCHEMBL11314107 0.71
SCHEMBL7063569 0.71
SCHEMBL2175556 0.71
SCHEMBL4546534 0.71
SCHEMBL10479479 0.71 TSHR (0.31)
SCHEMBL6324164 0.71 HDAC8 (0.35)
SCHEMBL11731955 0.70 LMNA (0.41)
Hydrochloric Acid SCHEMBL11189738 0.70 TSHR (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104109235-A Mono-functionalized polyethylene glycol with nitrogen atom branched center and its preparation method and biologically-relevant matter XIAMEN SINOPEG BIOTECH CO LTD 2014-10-22 CN claimed
CN-118355117-A Oligonucleotide compositions and methods thereof 波涛生命科学有限公司 2024-07-16 CN disclosed
CN-111936136-B Novel imidazopyrimidine compounds and uses thereof 儿童医学中心公司 2024-07-05 CN disclosed
CN-114736219-B Antitumor compounds 法马马有限公司 2024-06-07 CN disclosed
CN-114751920-B Antitumor compounds 法马马有限公司 2024-06-07 CN disclosed
CN-118139977-A Double-stranded oligonucleotide compositions and methods relating thereto 波涛生命科学有限公司 2024-06-04 CN disclosed
CN-118139629-A Compositions and methods for editing MECP2 transcripts 波涛生命科学有限公司 2024-06-04 CN disclosed
CN-118059096-A Methods of treating CNS disorders 杭州高光制药有限公司 2024-05-24 CN disclosed
US-20240166666-A1 ANTITUMORAL COMPOUNDS PHARMA MAR SA (ES) 2024-05-23 US disclosed
CN-118043459-A Chemically modified oligonucleotides 菲奥医药公司 2024-05-14 CN disclosed
CN-1468238-A Substituted pyrazoles ����-������ҩƷ��˾ 2004-01-14 CN disclosed
CN-1468221-A Non-imidazole aryloxypiperidines ����-������ҩƷ��˾ 2004-01-14 CN disclosed
US-20030220334-A1 Byrostatin analogues, synthetic methods and uses NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-11-27 US disclosed
US-20030211407-A1 Alkali-soluble siloxane polymer, positive type resist composition, resist pattern, process for forming the same, electronic device and process for manufacturing the same FUJITSU LIMITED (JP) 2003-11-13 US disclosed
CN-1448792-A Photosensitive paste SUMITOMO CHEMICAL CO (JP) 2003-10-15 CN disclosed
EP-1349007-A1 Photosensitive Paste SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2003-10-01 EP disclosed
WO-2003070719-A1 BRYOSTATIN ANALOGUES, SYNTHETIC METHODS AND USES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2003-08-28 WO disclosed
US-20030092854-A1 Resin composition for intermediate layer of three-layer resist SUMITOMO CHEMICAL COMPANY, LIMITED 2003-05-15 US disclosed
CN-1373660-A Method for treating chronic pain using MEK inhibitors WARNER LAMBERT CO (US) 2002-10-09 CN disclosed
CN-1260796-A Alkaloid halide salts of swainsonine and methods of use GLYCODESIGN INC (CA) 2000-07-19 CN disclosed